TABLE 2

Comparison of MBF, MFR, and CVR at Rest and During Pharmacologic Vasodilation in Baseline Evaluation and Caffeine Studies

Subject no.	MBF (mL/min/g)											MFR
		Baseline					Caffeine					Baseline			Caffeine			Baseline	Caffeine
		Rest	ATP	DIP	Rest	ATP	DIP	ATP	DIP	ATP	DIP	Rest	ATP	DIP	Rest	ATP	DIP
1	0.74	4.26	3.14	0.54	1.55	1.06	5.76	4.24	2.87	1.96	117.1	20.3	27.8	144.4	52.9	73.6
2	0.56	3.45	1.88	0.53	1.17	1.67	6.16	3.36	2.19	3.14	103.0	15.9	27.7	114.1	53.2	36.7
3	0.69	3.18	4.37	0.52	1.54	2.22	4.58	6.29	2.96	4.27	106.0	23.8	17.2	144.2	45.9	35.0
4	0.65	4.14	2.13	0.65	1.63	1.62	6.35	3.27	2.50	2.48	119.6	14.9	37.9	119.1	43.6	50.8
5	1.21	3.73	3.12	1.21	1.71	1.38	3.10	2.59	1.42	1.14	61.7	22.6	26.3	62.2	51.7	61.0
6	0.63	2.79	2.68	0.51	2.23	1.29	4.46	4.28	4.38	2.52	119.8	27.4	30.6	143.9	34.4	65.3
7	0.65	3.55	4.21	0.65	1.08	1.41	5.46	6.48	1.66	2.17	115.9	19.4	17.3	148.7	87.0	58.2
8	0.65	4.50	2.87	0.86	1.87	1.08	6.92	4.42	2.17	1.26	125.6	14.9	28.1	94.2	37.8	80.9
9	1.43	2.79	2.80	1.40	2.08	2.14	1.95	1.96	1.49	1.53	54.5	25.2	29.4	56.0	35.4	38.2
10	0.68	4.63	2.84	0.68	1.91	1.35	6.81	4.18	2.81	1.99	79.9	12.0	19.0	82.4	31.4	45.7
Mean	0.79	3.70	3.00	0.75	1.68	1.52	5.15	4.10	2.44	2.25	100.3	19.6	26.1	110.9	47.3	54.5
± SD	± 0.29	± 0.67*	± 0.79*^†	± 0.31	± 0.37^†^‡	± 0.40^‡	± 1.64	± 1.44	± 0.88^†	± 0.94	± 25.7	± 5.1*	± 6.6*	± 35.5	± 16.1^†^‡^‖	± 15.9^‡^‖